Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$70.23 - $86.01 $98 Million - $120 Million
1,396,074 New
1,396,074 $101 Billion
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $96.4 Million - $121 Million
1,434,301 New
1,434,301 $115 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $7.8 Million - $9.76 Million
-117,811 Reduced 7.47%
1,458,825 $97.2 Million
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $14.1 Million - $17.7 Million
212,385 Added 15.57%
1,576,636 $120 Million
Q1 2022

May 11, 2022

BUY
$66.02 - $79.71 $228,759 - $276,195
3,465 Added 0.25%
1,364,251 $108 Million
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $8.43 Million - $9.86 Million
-133,070 Reduced 8.91%
1,360,786 $99.9 Million
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $2.21 Million - $2.71 Million
-32,218 Reduced 2.11%
1,493,856 $103 Million
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $3.4 Million - $3.73 Million
42,573 Added 2.87%
1,526,074 $0
Q1 2021

May 13, 2021

BUY
$76.02 - $100.5 $327,418 - $432,853
4,307 Added 0.29%
1,483,501 $0
Q4 2020

Feb 09, 2021

BUY
$80.74 - $97.7 $1.06 Million - $1.28 Million
13,091 Added 0.89%
1,479,194 $0
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $4.05 Million - $5.22 Million
47,562 Added 3.35%
1,466,103 $0
Q2 2020

Aug 12, 2020

SELL
$74.18 - $108.93 $4.25 Million - $6.25 Million
-57,340 Reduced 3.89%
1,418,541 $0
Q1 2020

May 06, 2020

SELL
$63.18 - $85.97 $3.19 Million - $4.34 Million
-50,510 Reduced 3.31%
1,475,881 $0
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $8.08 Million - $10.6 Million
-110,620 Reduced 6.76%
1,526,391 $0
Q3 2019

Nov 07, 2019

BUY
$72.82 - $86.52 $5.87 Million - $6.97 Million
80,577 Added 5.18%
1,637,011 $0
Q2 2019

Aug 12, 2019

BUY
$73.52 - $88.7 $18.3 Million - $22.1 Million
249,110 Added 19.05%
1,556,434 $132 Million
Q1 2019

May 14, 2019

BUY
$63.56 - $88.17 $927,658 - $1.29 Million
14,595 Added 1.13%
1,307,324 $112 Million
Q4 2018

Feb 11, 2019

SELL
$58.5 - $69.94 $1.3 Million - $1.55 Million
-22,173 Reduced 1.69%
1,292,729 $82.2 Million
Q3 2018

Nov 09, 2018

SELL
$61.75 - $74.23 $910,380 - $1.09 Million
-14,743 Reduced 1.11%
1,314,902 $0
Q2 2018

Aug 06, 2018

SELL
$60.85 - $83.98 $3.33 Million - $4.6 Million
-54,742 Reduced 3.95%
1,329,645 $89.1 Million
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $24.7 Million - $30.1 Million
-297,632 Reduced 17.69%
1,384,387 $115 Million
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $157 Million - $196 Million
1,682,019
1,682,019 $159 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.